- Country: Sweden
- Summary: Vaccines 2024-2 Vaccine against Pneumococcal Infections
- SET Ref No: 126182005
- Deadline: 13 Oct 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: SEK 100000000
- Notice Type: Tender
- Document Ref. No.: 596944-2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The procurement includes delivery and distribution of vaccines against pneumococci with ATC code J07AL02 to meet the needs of the contracting authorities.
Delivery and distribution of vaccines against pneumococci with ATC Code J07AL02 to meet the needs of the contracting authorities.
Vaccine against pneumococcal disease according to the procurement document.
distribution of vaccine against pneumococci with ATC code J07AL02 to meet the needs of the contracting authorities.
Pneumococcal disease according to the procurement document.
vaccine mot Pneumokockinfektioner
Contract Type: supplies - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINVaccines 2024-2 Vaccine against Pneumococcal Infections - Sweden Tender
The ADDDA INSKOEPSCENTRAL AB, a Government sector organization in Sweden, has announced a new tender for Vaccines 2024-2 Vaccine against Pneumococcal Infections. This tender is published on SwedenTenders under SET Ref No: 126182005 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-10-13.
The estimated tender value is SEK 100000000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
